Silencing of K-Ras by siRNA [15], [16], miRNA [17], [18] or antisense K-Ras [19] has been shown to result in reversal of transformed phenotypes and suppression of tumorigenicity in human cancer cells. This evidence concerns the gene KRAS and cancer.